KAM

Krensavage Asset Management Portfolio holdings

AUM $189M
This Quarter Return
+8.76%
1 Year Return
+19.71%
3 Year Return
+56.44%
5 Year Return
+120.01%
10 Year Return
+215.64%
AUM
$319M
AUM Growth
+$319M
Cap. Flow
+$8.59M
Cap. Flow %
2.7%
Top 10 Hldgs %
97.56%
Holding
14
New
1
Increased
3
Reduced
9
Closed
1

Top Buys

1
EXEL icon
Exelixis
EXEL
$21.1M
2
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
$2.06M
3
BIIB icon
Biogen
BIIB
$1.61M
4
TARO
Taro Pharmaceutical Industries Ltd.
TARO
$119K

Top Sells

1
ALKS icon
Alkermes
ALKS
$7.61M
2
REGN icon
Regeneron Pharmaceuticals
REGN
$5.42M
3
UTHR icon
United Therapeutics
UTHR
$2.29M
4
MCK icon
McKesson
MCK
$368K
5
ANAB icon
AnaptysBio
ANAB
$282K

Sector Composition

1 Healthcare 98.67%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ENTA icon
1
Enanta Pharmaceuticals
ENTA
$180M
$53.2M 16.69% 936,777 -2,873 -0.3% -$163K
ALKS icon
2
Alkermes
ALKS
$4.78B
$44.5M 13.95% 1,441,967 -246,874 -15% -$7.61M
REGN icon
3
Regeneron Pharmaceuticals
REGN
$61.5B
$44.3M 13.89% 73,143 -8,961 -11% -$5.42M
UTHR icon
4
United Therapeutics
UTHR
$13.8B
$38.3M 12% 207,287 -12,403 -6% -$2.29M
TARO
5
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$34.7M 10.89% 545,583 +1,878 +0.3% +$119K
MCK icon
6
McKesson
MCK
$85.4B
$32.8M 10.29% 164,591 -1,845 -1% -$368K
BIIB icon
7
Biogen
BIIB
$19.4B
$29.2M 9.16% 103,202 +5,679 +6% +$1.61M
EXEL icon
8
Exelixis
EXEL
$10.1B
$21.1M 6.63% +1,000,000 New +$21.1M
SRGA
9
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$6.9M 2.17% 6,332,945 -70,132 -1% -$76.4K
EGRX
10
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$6.01M 1.89% 107,773 +36,969 +52% +$2.06M
IVC
11
DELISTED
Invacare Corporation
IVC
$4.24M 1.33% 891,259 -10,453 -1% -$49.8K
TVTX icon
12
Travere Therapeutics
TVTX
$1.56B
$3.33M 1.04% 137,203 -2,797 -2% -$67.8K
NXTC icon
13
NextCure
NXTC
$13.5M
$208K 0.07% 30,927 -428 -1% -$2.88K
ANAB icon
14
AnaptysBio
ANAB
$569M
– – -10,890 Closed -$282K